ASCO 2024: Updates in Multiple Myeloma

home / post-conference-perspectives / asco-2024-updates-in-multiple-myeloma

Alfred L. Garfall, MD, shares insights to recent data surrounding the multiple myeloma treatment landscape as presented at ASCO 2024 in Chicago, Illinois.

EP. 1: Unmet Needs in Multiple Myeloma Ahead of ASCO 2024

June 28th 2024

Alfred L. Garfall, MD, opens a discussion underscoring the unmet needs in multiple myeloma.

Watch

EP. 2: Long-Term Follow-Up Data from MajesTEC-1 at ASCO 2024

July 10th 2024

Dr Garfall, MD, provides insights following results derived from the MajesTEC-1 study.

Watch

EP. 3: MajesTEC-1 and the Value of Long-Term Follow-Up Data from ASCO 2024

July 12th 2024

Dr Garfall, MD, provides further insights around the MajesTEC-1 study.

Watch

EP. 4: Use of Prophylactic Tocilizumab with Teclistamab: Takeaways from ASCO 2024

Alfred L. Garfall, MD

July 17th 2024

Alfred L. Garfall, MD, discusses long-term follow-up data from the MajesTEC-1 study presented at ASCO 2024.

Watch

EP. 5: ASCO 2024: DREAMM-8 Study of Belantamab Mafodotin, Pomalidomide, and Dexamethasone

Alfred L. Garfall, MD

July 19th 2024

Alfred L. Garfall, MD, discusses follow-up data from the DREAMM-8 study presented at ASCO 2024.

Watch

EP. 6: Future Directions in the Management of Multiple Myeloma

Alfred L. Garfall, MD

July 24th 2024

Alfred L. Garfall, MD, discusses his hopes for the future treatment landscape of multiple myeloma.

Watch

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777